CN111000975A - Preparation method of peach gum soft capsule for reducing blood sugar - Google Patents
Preparation method of peach gum soft capsule for reducing blood sugar Download PDFInfo
- Publication number
- CN111000975A CN111000975A CN202010047089.2A CN202010047089A CN111000975A CN 111000975 A CN111000975 A CN 111000975A CN 202010047089 A CN202010047089 A CN 202010047089A CN 111000975 A CN111000975 A CN 111000975A
- Authority
- CN
- China
- Prior art keywords
- peach gum
- solution
- soft capsule
- blood sugar
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000006040 Prunus persica var persica Nutrition 0.000 title claims abstract description 56
- 239000007901 soft capsule Substances 0.000 title claims abstract description 31
- 239000008280 blood Substances 0.000 title claims abstract description 28
- 210000004369 blood Anatomy 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 240000006413 Prunus persica var. persica Species 0.000 title 1
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 54
- 239000000243 solution Substances 0.000 claims description 34
- 241000229143 Hippophae Species 0.000 claims description 32
- 150000004676 glycans Chemical class 0.000 claims description 32
- 229920001282 polysaccharide Polymers 0.000 claims description 32
- 239000005017 polysaccharide Substances 0.000 claims description 32
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims description 28
- 235000018102 proteins Nutrition 0.000 claims description 23
- 108090000623 proteins and genes Proteins 0.000 claims description 23
- 102000004169 proteins and genes Human genes 0.000 claims description 23
- 235000012424 soybean oil Nutrition 0.000 claims description 17
- 239000003549 soybean oil Substances 0.000 claims description 17
- 238000002156 mixing Methods 0.000 claims description 15
- 244000068988 Glycine max Species 0.000 claims description 14
- 235000010469 Glycine max Nutrition 0.000 claims description 14
- 229910019142 PO4 Inorganic materials 0.000 claims description 14
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 14
- 239000010452 phosphate Substances 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 235000013871 bee wax Nutrition 0.000 claims description 13
- 239000012166 beeswax Substances 0.000 claims description 13
- 235000012054 meals Nutrition 0.000 claims description 9
- 239000002775 capsule Substances 0.000 claims description 7
- 241001467578 Microbacterium Species 0.000 claims description 6
- 230000001105 regulatory effect Effects 0.000 claims description 6
- 238000000926 separation method Methods 0.000 claims description 6
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 239000003292 glue Substances 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 239000012460 protein solution Substances 0.000 claims description 3
- 229940083466 soybean lecithin Drugs 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 4
- 201000001421 hyperglycemia Diseases 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract description 3
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 235000015097 nutrients Nutrition 0.000 abstract description 2
- 108010010803 Gelatin Proteins 0.000 description 21
- 229920000159 gelatin Polymers 0.000 description 21
- 239000008273 gelatin Substances 0.000 description 21
- 235000019322 gelatine Nutrition 0.000 description 21
- 235000011852 gelatine desserts Nutrition 0.000 description 21
- 238000003756 stirring Methods 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- 239000006187 pill Substances 0.000 description 6
- 238000007873 sieving Methods 0.000 description 6
- 239000000084 colloidal system Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 235000003935 Hippophae Nutrition 0.000 description 4
- 238000000861 blow drying Methods 0.000 description 4
- 239000007766 cera flava Substances 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 230000002452 interceptive effect Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000002791 soaking Methods 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000003094 microcapsule Substances 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/145—Extraction; Separation; Purification by extraction or solubilisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Abstract
The invention relates to the technical field of nutrient product production, in particular to a preparation method of a peach gum soft capsule for reducing blood sugar. The soft capsule health care product prepared by the preparation method of the peach gum soft capsule for reducing blood sugar has beautiful appearance, definite components, safety, reliability and no side effect, and has obvious effect of reducing hyperglycemia caused by type II diabetes.
Description
Technical Field
The invention relates to the technical field of production of nutritional products, in particular to a preparation method of a peach gum soft capsule for reducing blood sugar.
Background
Peach gum is a colloid semitransparent substance secreted by rose plant trunks after mechanical damage (such as insect bite, cutting wound and the like) or disease. According to the record of the original peach gum in Bencao gang mu, the bark is cut by a knife when the peach is full, the gum overflows after a long time, the peach gum is collected, the mulberry leaf ash decoction is soaked for drying, Minyao can become the peach gum recorded in food Bencao, the peach gum has the characteristics of bitter taste, smoothness and no toxicity, and the peach gum can be taken after refining, can keep the middle warmer and not hungry, harmonize blood and tonify qi, and remove stranguria caused by stone and relieve pain. The sea-buckthorn is rich in various chemical substances and bioactive components, is a tree species containing the most natural vitamins in the world, and is rich in more than 200 natural components and nutrient substances such as polyphenols, proteins, fatty acids and the like in the body.
The peach gum is interacted with the intestinal microorganisms in vivo, and is polysaccharide or metabolite of intestinal flora which is degraded and changed in the type and the quantity of the intestinal microorganisms has an influence on the blood sugar level, and the peach gum polysaccharide can obviously reduce the blood sugar level and the blood fat level. The sea buckthorn protein has the function of reducing blood sugar, has the function of reducing the weight of type II diabetic mice, and has the function of improving the symptoms of hyperlipidemia and hyperglycemia of the mice.
The soft capsule is prepared from gelatin, glycerol or other suitable medicinal adjuvants, and can be used alone or in combination.
The applicant researches and discovers that the original peach gum has a remarkable curative effect on the aspect of treating diabetes. The extracted protopanoxadiol polysaccharide can obviously reduce the blood sugar and blood fat levels of rats with type II diabetes models. The mechanism of polysaccharide to lower blood sugar is mainly focused on the following aspects:improve the cell shape and function of insulin and promote the secretion of insulin;increase insulin sensitivity;improving activity of a carbohydrate metabolism-related enzyme;the sea buckthorn protein has the function of reducing blood sugar, has the efficacy of reducing the weight of a type II diabetic mouse, and has the efficacy of improving the symptoms of hyperlipidemia and hyperglycemia of the mouse.
Disclosure of Invention
The invention provides a preparation method of peach gum soft capsules for reducing blood sugar, which comprises the steps of taking seabuckthorn seed meal as a main drug effect substance, extracting peach gum polysaccharide from raw peach gum through fermentation, crushing, dissolving, centrifuging, drying, mixing ingredients, sieving, packaging, processing a finished product, and preparing the peach gum microcapsules by using a soft capsule dripping pill technology.
The technical scheme adopted by the invention for solving the technical problems is as follows: a preparation method of peach gum soft capsules for reducing blood sugar comprises the following steps: (1) selecting materials: peach gum polysaccharide, sea buckthorn protein, beeswax, soybean oil and soybean phosphate; (2) and preparing peach gum polysaccharide: fermenting at 35-40 deg.C and pH of 2-6 to obtain peach gum polysaccharide solution I; the peach gum polysaccharide is fermented by using microbacterium, and 10% -14% of peach gum is utilized by the microbacterium; (3) and preparing the sea-buckthorn protein: extracting the sea buckthorn seed meal solution at a set temperature of 50-60 ℃ for 50-70min, carrying out centrifugal separation, regulating the pH of a supernatant to 5.0 with an acid solution, carrying out centrifugal separation, washing a precipitate with water for 2 times, regulating the pH of a small amount of deionized water to 6.5-7.5, carrying out vacuum freeze drying to obtain sea buckthorn seed meal protein, and preparing a sea buckthorn protein solution II; (4) mixing soybean oil, beeswax and soybean lecithin into a solution II, mixing the peach gum polysaccharide solution I with the mixed solution II to form a capsule glue solution, and preparing the soft capsule at the temperature of 35-48 ℃.
Further, the preparation method comprises the following steps of (4): 20-40 g of peach gum polysaccharide, 25-45 g of sea buckthorn protein, 28-32 g of beeswax, 10-20 g of soybean oil and 5-10 g of soybean phosphate.
The invention has the beneficial effects that the preparation method of the peach gum soft capsule for reducing blood sugar adopts seabuckthorn seed meal as a main drug effect substance, peach gum polysaccharide is extracted from raw peach gum through fermentation, seabuckthorn seed meal is subjected to crushing, dissolving, centrifuging, drying, mixing, sieving, packaging and finished product processing, the peach gum microcapsule is prepared by utilizing a soft capsule dropping pill technology, and the prepared soft capsule health-care product has beautiful appearance, definite components, safety, reliability and no side effect, and has obvious effect on reducing hyperglycemia caused by type II diabetes.
Drawings
The invention is further illustrated with reference to the following figures and examples.
FIG. 1 is a flow chart of the production process of the present invention.
Detailed Description
Fig. 1 is a production process flow chart of the invention, and the preparation method of the peach gum soft capsule for reducing blood sugar comprises the following steps: (1) selecting materials: peach gum polysaccharide, sea buckthorn protein, beeswax, soybean oil and soybean phosphate; (2) and preparing peach gum polysaccharide: fermenting at 35-40 deg.C and pH of 2-6 to obtain peach gum polysaccharide solution I; the peach gum polysaccharide is fermented by using microbacterium, and 10% -14% of peach gum is utilized by the microbacterium; (3) and preparing the sea-buckthorn protein: extracting the sea buckthorn seed meal solution at a set temperature of 50-60 ℃ for 50-70min, carrying out centrifugal separation, regulating the pH of a supernatant to 5.0 with an acid solution, carrying out centrifugal separation, washing a precipitate with water for 2 times, regulating the pH of a small amount of deionized water to 6.5-7.5, carrying out vacuum freeze drying to obtain sea buckthorn seed meal protein, and preparing a sea buckthorn protein solution II; (4) mixing soybean oil, beeswax and soybean lecithin into a solution II, mixing the peach gum polysaccharide solution I with the mixed solution II to form a capsule glue solution, and preparing the soft capsule at the temperature of 35-48 ℃. The components in the step (4) are mixed according to the weight ratio as follows: 20-40 g of peach gum polysaccharide, 25-45 g of sea buckthorn protein, 28-32 g of beeswax, 10-20 g of soybean oil and 5-10 g of soybean phosphate.
The first embodiment is as follows: in the embodiment, interfering impurities are extracted and removed for multiple times, effective blood sugar reducing components are reserved, and 20g of peach gum polysaccharide, 25g of sea buckthorn protein, 28g of beeswax, 10g of soybean phosphate and 20g of soybean oil are added and mixed to obtain the soft capsule capable of reducing blood sugar, wherein the preparation method comprises the following steps: heating soybean oil to 30 deg.C, adding 28g Cera flava, 20g peach gum polysaccharide and 25g fructus Hippophae protein, stirring, adding 10g soybean phosphate, stirring, grinding with colloid mill, sieving with 80 mesh sieve, and repeating for 3 times to obtain suspension; soaking gelatin in water to obtain gelatin solution, mixing gelatin solution with suspension and water at a certain weight ratio to obtain mixed gelatin solution, making the gelatin solution into soft capsule of 8g each by soft capsule dripping pill, standing at 30 deg.C, grading, blow drying, and making into capsule.
The second embodiment is as follows: the soft capsule capable of reducing blood sugar is obtained by extracting and removing interfering impurities for multiple times, keeping components capable of effectively reducing blood sugar, and adding 25g of peach gum polysaccharide, 30g of sea buckthorn protein, 28g of beeswax, 10g of soybean phosphate and 20g of soybean oil for mixing, and the preparation method is as follows: heating soybean oil to 30 deg.C, adding 28g Cera flava, 25g peach gum polysaccharide and 30g fructus Hippophae protein, stirring, adding 10g soybean phosphate, stirring, grinding with colloid mill, sieving with 80 mesh sieve, and repeating for 3 times to obtain suspension; soaking gelatin in water to obtain gelatin solution, mixing gelatin solution with suspension and water at a certain weight ratio to obtain mixed gelatin solution, making the gelatin solution into soft capsule of 8g each by soft capsule dripping pill, standing at 30 deg.C, grading, blow drying, and making into capsule.
The third concrete embodiment: the soft capsule capable of reducing blood sugar is obtained by extracting and removing interfering impurities for multiple times, keeping components capable of effectively reducing blood sugar, and adding 30g of peach gum polysaccharide, 30g of sea buckthorn protein, 28g of beeswax, 10g of soybean phosphate and 20g of soybean oil for mixing, and the preparation method is as follows: heating soybean oil to 30 deg.C, adding 28g Cera flava, 30g peach gum polysaccharide and 35g fructus Hippophae protein, stirring, adding 10g soybean phosphate, stirring, grinding with colloid mill, sieving with 80 mesh sieve, and repeating for 3 times to obtain suspension; soaking gelatin in water to obtain gelatin solution, mixing gelatin solution with suspension and water at a certain weight ratio to obtain mixed gelatin solution, making the gelatin solution into soft capsule of 8g each by soft capsule dripping pill, standing at 30 deg.C, grading, blow drying, and making into capsule.
The fourth concrete embodiment: the soft capsule capable of reducing blood sugar is obtained by extracting and removing interfering impurities for multiple times, keeping components capable of effectively reducing blood sugar, and adding 30g of peach gum polysaccharide, 25g of sea buckthorn protein, 28g of beeswax, 10g of soybean phosphate and 20g of soybean oil for mixing, and the preparation method is as follows: heating soybean oil to 30 deg.C, adding 28g Cera flava, 30g peach gum polysaccharide and 25g fructus Hippophae protein, stirring, adding 10g soybean phosphate, stirring, grinding with colloid mill, sieving with 80 mesh sieve, and repeating for 3 times to obtain suspension; soaking gelatin in water to obtain gelatin solution, mixing gelatin solution with suspension and water at a certain weight ratio to obtain mixed gelatin solution, making the gelatin solution into soft capsule of 8g each by soft capsule dripping pill, standing at 30 deg.C, grading, blow drying, and making into capsule.
The foregoing description is intended to be illustrative rather than limiting, and it will be appreciated by those skilled in the art that many modifications, variations or equivalents may be made without departing from the spirit and scope of the invention as defined in the appended claims.
Claims (2)
1. A preparation method of peach gum soft capsules for reducing blood sugar is characterized by comprising the following steps: (1) selecting materials: peach gum polysaccharide, sea buckthorn protein, beeswax, soybean oil and soybean phosphate; (2) and preparing peach gum polysaccharide: fermenting at 35-40 deg.C and pH of 2-6 to obtain peach gum polysaccharide solution I; the peach gum polysaccharide is fermented by using microbacterium, and 10% -14% of peach gum is utilized by the microbacterium; (3) and preparing the sea-buckthorn protein: extracting the sea buckthorn seed meal solution at a set temperature of 50-60 ℃ for 50-70min, carrying out centrifugal separation, regulating the pH of a supernatant to 5.0 with an acid solution, carrying out centrifugal separation, washing a precipitate with water for 2 times, regulating the pH of a small amount of deionized water to 6.5-7.5, carrying out vacuum freeze drying to obtain sea buckthorn seed meal protein, and preparing a sea buckthorn protein solution II; (4) mixing soybean oil, beeswax and soybean lecithin into a solution II, mixing the peach gum polysaccharide solution I with the mixed solution II to form a capsule glue solution, and preparing the soft capsule at the temperature of 35-48 ℃.
2. The preparation method of the peach gum soft capsule for reducing blood sugar according to claim 1, wherein the components in the step (4) are mixed according to the following weight ratio: 20-40 g of peach gum polysaccharide, 25-45 g of sea buckthorn protein, 28-32 g of beeswax, 10-20 g of soybean oil and 5-10 g of soybean phosphate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010047089.2A CN111000975A (en) | 2020-01-16 | 2020-01-16 | Preparation method of peach gum soft capsule for reducing blood sugar |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010047089.2A CN111000975A (en) | 2020-01-16 | 2020-01-16 | Preparation method of peach gum soft capsule for reducing blood sugar |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111000975A true CN111000975A (en) | 2020-04-14 |
Family
ID=70120759
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010047089.2A Pending CN111000975A (en) | 2020-01-16 | 2020-01-16 | Preparation method of peach gum soft capsule for reducing blood sugar |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111000975A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114009766A (en) * | 2021-11-17 | 2022-02-08 | 钱宝鸿 | Dietetic therapy composition for conditioning hypertension, hyperglycemia and hyperlipidemia and preparation method thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102178821A (en) * | 2011-04-28 | 2011-09-14 | 柳正良 | Soft capsules for reducing blood sugar and preparation method thereof |
US20130099403A1 (en) * | 2010-07-05 | 2013-04-25 | Jianzhong Ma | Semen cassiae soft capsule for reducing fat and losing weight and preparation method thereof |
CN105061617A (en) * | 2015-07-31 | 2015-11-18 | 华中农业大学 | Extraction process and application of peach gum polysaccharide |
CN106046113A (en) * | 2016-08-03 | 2016-10-26 | 西南科技大学 | Method for extracting sea-buckthorn protein from sea-buckthorn seed meal |
CN110684090A (en) * | 2019-10-09 | 2020-01-14 | 完美(广东)日用品有限公司 | Alpha-amylase inhibitor and preparation process and application thereof |
-
2020
- 2020-01-16 CN CN202010047089.2A patent/CN111000975A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130099403A1 (en) * | 2010-07-05 | 2013-04-25 | Jianzhong Ma | Semen cassiae soft capsule for reducing fat and losing weight and preparation method thereof |
CN102178821A (en) * | 2011-04-28 | 2011-09-14 | 柳正良 | Soft capsules for reducing blood sugar and preparation method thereof |
CN105061617A (en) * | 2015-07-31 | 2015-11-18 | 华中农业大学 | Extraction process and application of peach gum polysaccharide |
CN106046113A (en) * | 2016-08-03 | 2016-10-26 | 西南科技大学 | Method for extracting sea-buckthorn protein from sea-buckthorn seed meal |
CN110684090A (en) * | 2019-10-09 | 2020-01-14 | 完美(广东)日用品有限公司 | Alpha-amylase inhibitor and preparation process and application thereof |
Non-Patent Citations (2)
Title |
---|
刘洪霞: "沙棘蛋白的特性及其对db_db糖尿病小鼠的降血糖作用", 《食品工业科技》 * |
邹信: "桃胶裂解菌株的分离鉴定及产酶条件研究", 《中国优秀硕士学位论文全文数据库 (基础科学辑)》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114009766A (en) * | 2021-11-17 | 2022-02-08 | 钱宝鸿 | Dietetic therapy composition for conditioning hypertension, hyperglycemia and hyperlipidemia and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103494199B (en) | Peony seed oil soft capsule with lipid-lowering effect and preparation method thereof | |
CN101700094B (en) | Method for preparing low sugar edible fungi mushroom | |
CN102406108A (en) | Cherry jam and preparation method thereof | |
CN109645197A (en) | A kind of preparation method of Mulberry fruit cake | |
CN103975991A (en) | Healthcare mulberry anthocyanidin biscuit | |
CN101664180B (en) | Health-care nutritional complexing agent with health effect and preparation method thereof | |
CN101152239A (en) | Technique of preparing drone pupa freeze-dried powder medicinal granules and capsule | |
CN104106752A (en) | Snake feed for preventing and treating cold and pneumonia of snakes and production method thereof | |
KR20070005317A (en) | Health supporting food for a diabetic with a jerusalem artichoke as main material | |
CN111000975A (en) | Preparation method of peach gum soft capsule for reducing blood sugar | |
CN109170313A (en) | A kind of anti-heat stress egg feedstuff compound additive and preparation method thereof | |
CN105394680A (en) | Guiling jelly having skin improving effect and preparation method thereof | |
CN108684819A (en) | A kind of teenager's fruits and vegetables dairy beverage and preparation method thereof | |
KR20120111587A (en) | Functional rice for blood sugar down and making method thereof | |
CN107811095A (en) | A kind of preparation method of the compound pressed candy of pomegranate jujube | |
CN104585574A (en) | Propolis soft capsule product and preparation method thereof | |
CN102524708A (en) | Yuge powder with functions of weight loss and beauty and preparation method for Yuge powder | |
CN102987405B (en) | Method for preparing health food capsules by using cordyceps militaris and cocoon extracts | |
CN105087335A (en) | Rhodomyrtus tomentosa wine and processing method thereof | |
KR20110014418A (en) | A hot spice | |
KR101195316B1 (en) | High a-Glucosidase Inhibitors Gochujang | |
CN105029431B (en) | A kind of mulberry skin powder, preparation method and applications | |
CN115068559B (en) | Plant-based compound oral liquid with auxiliary blood sugar reducing effect and preparation method thereof | |
CN107173659A (en) | A kind of Moringa solid beverage and preparation method thereof | |
CN106360690A (en) | Method for preparing enzymes with smoked plum and turmeric as principal raw materials |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200414 |
|
RJ01 | Rejection of invention patent application after publication |